SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022884
Filing Date
2020-05-07
Accepted
2020-05-07 16:18:45
Documents
57
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eigr-10q_20200331.htm 10-Q 1681768
2 EX-10.1 eigr-ex101_191.htm EX-10.1 63859
3 EX-10.2 eigr-ex102_190.htm EX-10.2 82289
4 EX-31.1 eigr-ex311_11.htm EX-31.1 16841
5 EX-31.2 eigr-ex312_12.htm EX-31.2 16905
6 EX-32.1 eigr-ex321_6.htm EX-32.1 5739
7 GRAPHIC gs13ob02qffq000001.jpg GRAPHIC 39083
  Complete submission text file 0001564590-20-022884.txt   5830421

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT eigr-20200331.xml EX-101.INS 1184245
9 XBRL TAXONOMY EXTENSION SCHEMA eigr-20200331.xsd EX-101.SCH 41190
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eigr-20200331_cal.xml EX-101.CAL 42215
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eigr-20200331_def.xml EX-101.DEF 120258
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE eigr-20200331_lab.xml EX-101.LAB 328830
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eigr-20200331_pre.xml EX-101.PRE 245201
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36183 | Film No.: 20856709
SIC: 2836 Biological Products, (No Diagnostic Substances)